HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-01-05Clinical Trial Update: Depression Amongst HIV Positive Patients in Lilongwe
This is a completed clinical trial evaluating depression among HIV-positive patients in Lilongwe. The provided snippet does not include stud…
-
CLINICAL_TRIALS trial_result · 2016-01-01Clinical Trial Update: Addition of Ezetimibe (Ezetrol®) to Ongoing Therapy With Rosuvastatin (Crestor®) in HIV Positive Patients Not Reaching Cholesterol Targets [NA]
A completed clinical trial evaluated adding ezetimibe to ongoing rosuvastatin therapy in HIV-positive patients not reaching cholesterol targ…
-
FDA label_change · 2015-12-31FDA Approved: LAMIVUDINE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for lamivudine by Apotex Corp., indicating a labeling-related change under the ANDA.
-
CLINICAL_TRIALS trial_result · 2015-12-30Clinical Trial Update: Renal and Bone Outcome After Switching Tenofovir to Different Antiretroviral Strategies
This clinical trial update reports renal and bone outcomes after switching from tenofovir disoproxil fumarate to alternative antiretroviral …
-
CLINICAL_TRIALS trial_result · 2015-12-30Clinical Trial Update: Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With HIV Infection and Modestly Detectable Viral Load. [Phase 2]
A Phase 2 safety and antiviral study of ACH-126, 443 (Beta-L-Fd4C) in adults with HIV infection and modestly detectable viral load has been …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2015-12-30Clinical Trial Update: Pilot Study of Maraviroc/Raltegravir for Naive HIV-1 Patients [Phase 2]
A Phase 2 pilot study evaluating a combination of maraviroc and raltegravir in treatment-naive HIV-1 patients is reported as a clinical tria…
-
FDA approval · 2015-12-29FDA Approved: COMPLERA — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for COMPLERA (emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate) from …
-
CLINICAL_TRIALS trial_result · 2015-12-24Clinical Trial Update: Antiretroviral Therapy and Inflammatory and Coagulation Biomarkers: iMACS Study
Update on the iMACS trial evaluating antiretroviral therapy and its effects on inflammatory and coagulation biomarkers; the study has comple…
-
FDA approval · 2015-12-22FDA Approved: ABACAVIR AND LAMIVUDINE — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approves Camber Pharmaceuticals' supplemental application for a generic abacavir/lamivudine combination product for HIV-1 infection.
-
CLINICAL_TRIALS trial_result · 2015-12-22Clinical Trial Update: Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women [Phase 2]
Phase 2 study assessing pharmacokinetic interactions between depot medroxyprogesterone acetate (DMPA) and lopinavir/ritonavir (LPV/r) in HIV…
-
CLINICAL_TRIALS research · 2015-12-22Clinical Trial Update: Tenofovir, Emtricitabine and Efavirenz Late Switch to a Single Pill: Patients' Opinion Survey
This clinical trial update reports patients' opinions on switching to a single-pill fixed-dose combination of tenofovir, emtricitabine, and …
-
CLINICAL_TRIALS trial_result · 2015-12-22Clinical Trial Update: Antiretroviral Adherence Evaluation in HIV Pregnant and Postpartum Women
This update notes the completion of a clinical trial evaluating adherence to antiretroviral therapy among HIV-infected pregnant and postpart…
-
CLINICAL_TRIALS trial_result · 2015-12-21Clinical Trial Update: Vicriviroc in HIV(R5/X4)-Treatment Experienced Subjects (Study P05057AM5)(COMPLETED) [Phase 2]
This is an update on a completed Phase 2 trial of vicriviroc in treatment-experienced HIV-infected subjects.
-
CLINICAL_TRIALS trial_result · 2015-12-21Clinical Trial Update: A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines [Phase 2, Phase 3]
Phase II/III trial evaluating lopinavir/ritonavir dosing according to WHO pediatric weight-band guidelines in HIV; study completed with resu…
-
CLINICAL_TRIALS trial_result · 2015-12-18Clinical Trial Update: Bryostatin-1 Effect on HIV-1 Latency and Reservoir in HIV-1 Infected Patients Receiving Antiretroviral Treatment [Phase 1]
Phase 1 clinical trial evaluating Bryostatin-1 for its effect on HIV-1 latency and reservoirs in patients on antiretroviral therapy has been…
-
CLINICAL_TRIALS trial_result · 2015-12-18Clinical Trial Update: Effect of Cytoreductive Chemotherapy and a CCR5 Coreceptor Antagonist on HIV-1 Eradication [EARLY_Phase 1]
An early-phase HIV eradication trial combining cytoreductive chemotherapy with a CCR5 coreceptor antagonist was terminated before completion…
-
CLINICAL_TRIALS trial_result · 2015-12-17Clinical Trial Update: Safety and Efficacy Study of Daclatasvir (BMS-790052) Plus Pegylated Interferon-Alfa 2a and Ribavirin in Patients Coinfected With Untreated Hepatitis C Virus and HIV Virus [Phase 3]
Phase 3 safety and efficacy study of daclatasvir with pegylated interferon alfa-2a and ribavirin in patients with untreated hepatitis C geno…
-
CLINICAL_TRIALS trial_result · 2015-12-15Clinical Trial Update: Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru [NA]
The NIAID-sponsored study completed a feasibility assessment for measuring immune activation in foreskin/mucosal tissue among HIV-negative, …
-
CLINICAL_TRIALS research · 2015-12-14Clinical Trial Update: The Canadian HIV Quit Smoking Trial: Tackling the Co-morbidities of Depression and Cardiovascular Disease in HIV+ Smokers [Phase 3]
This clinical trial update describes a Phase 3 study in HIV-positive smokers aimed at improving smoking cessation and addressing depression …
-
FDA approval · 2015-12-11FDA Approved: ZIDOVUDINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Zidovudine submitted by Aurobindo Pharma Limited. The approval confirms continued authorization …
-
FDA approval · 2015-12-11FDA Approved: ABACAVIR SULFATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Abacavir Sulfate from Mylan Pharmaceuticals Inc.
-
CLINICAL_TRIALS research · 2015-12-11Clinical Trial Update: T1 Mapping in HIV Patients With High and Low CD4+ Cell Counts
Clinical trial evaluating T1 mapping in HIV patients with varying CD4+ counts to characterize cardiac tissue changes.
-
CLINICAL_TRIALS trial_result · 2015-12-10Clinical Trial Update: Study of Maraviroc (MVC) and Epzicom (ABC/3TC) Once-Daily in ART-Naive & First Switch Patients
A completed study evaluating once-daily maraviroc with Epzicom (abacavir/lamivudine) in ART-naive and first-switch HIV patients.
-
CLINICAL_TRIALS withdrawal · 2015-12-10Clinical Trial Update: A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in South Africa [Phase 1, Phase 2]
A Phase 1/2 safety study of the dapivirine vaginal gel for HIV prevention in South Africa has been withdrawn.
-
CLINICAL_TRIALS research · 2015-12-07Clinical Trial Update: Pediatric Enhanced Surveillance Study
The pediatric enhanced surveillance trial (NCT02043769) has completed; no results are provided in the update.